Larotrectinib versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-Patient Comparative Analysis.
Italiano A, Nanda S, Briggs A, Garcia-Foncillas J, Lassen U, Vassal G, Kummar S, van Tilburg CM, Hong DS, Laetsch TW, Keating K, Reeves JA, Fellous M, Childs BH, Drilon A, Hyman DM.
Italiano A, et al. Among authors: fellous m.
Cancers (Basel). 2020 Nov 4;12(11):3246. doi: 10.3390/cancers12113246.
Cancers (Basel). 2020.
PMID: 33158040
Free PMC article.